home Search results for 'Colorectal Cancer'
Apparatus

Two-Drug Combination For Specific Mutation Colorectal Cancer With 100% Efficiency!

A study at Massachusetts General Hospital in the US demonstrated that Adagrasib alone and in combination with cetuximab delivered good results in patients with advanced colorectal cancer with KRAS G12C mutations, with 46% of subjects experiencing substantial tumour shrinkage and an efficacy rate of 100%.

Apparatus

Cancer Vaccine Shows Its Power! Survival Of Patients With Advanced Colorectal Cancer Extended By More Than 3 Times!

Data from a study of a cancer vaccine combined with a PD-1 immune checkpoint inhibitor has recently been released, and the treatment has increased the survival of patients with advanced colorectal cancer by more than three times, with some patients surviving for more than 22 months so far.